Technetium Tc 99m Medronate
"Technetium Tc 99m Medronate" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A gamma-emitting radionuclide imaging agent used primarily in skeletal scintigraphy. Because of its absorption by a variety of tumors, it is useful for the detection of neoplasms.
| Descriptor ID |
D013669
|
| MeSH Number(s) |
D02.691.825.750 D02.705.429.500.885
|
| Concept/Terms |
Technetium Tc 99m Medronate- Technetium Tc 99m Medronate
- Tc-99 Medronate
- Medronate, Tc-99
- Tc 99 Medronate
- Technetium Methylene Diphosphonate
- Diphosphonate, Technetium Methylene
- Methylene Diphosphonate, Technetium
- Technetium Tc 99m Methylenediphosphonate
- 99mTc-Methylene Diphosphonate
- 99mTc Methylene Diphosphonate
- Diphosphonate, 99mTc-Methylene
- 99mTc-MDP
- Tc-99m MDP
- Tc-99m Methylene Diphosphonate
- Diphosphonate, Tc-99m Methylene
- Methylene Diphosphonate, Tc-99m
- Tc 99m Methylene Diphosphonate
|
Below are MeSH descriptors whose meaning is more general than "Technetium Tc 99m Medronate".
Below are MeSH descriptors whose meaning is more specific than "Technetium Tc 99m Medronate".
This graph shows the total number of publications written about "Technetium Tc 99m Medronate" by people in this website by year, and whether "Technetium Tc 99m Medronate" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1997 | 1 | 0 | 1 |
| 1998 | 1 | 1 | 2 |
| 1999 | 0 | 1 | 1 |
| 2002 | 0 | 1 | 1 |
| 2003 | 2 | 0 | 2 |
| 2004 | 0 | 1 | 1 |
| 2005 | 1 | 0 | 1 |
| 2006 | 1 | 0 | 1 |
| 2024 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Technetium Tc 99m Medronate" by people in Profiles.
-
Hansen CL, Farber J, Binder A, Reist K, Brailovsky Y. Conversion of PYP/HMDP scanning on sequential imaging in a patient with a TTR gene mutation. J Nucl Cardiol. 2024 07; 37:101780.
-
Fujimoto R, Higashi T, Nakamoto Y, Hara T, Lyshchik A, Ishizu K, Kawashima H, Kawase S, Fujita T, Saga T, Togashi K. Diagnostic accuracy of bone metastases detection in cancer patients: comparison between bone scintigraphy and whole-body FDG-PET. Ann Nucl Med. 2006 Jul; 20(6):399-408.
-
James B, Chandler NC, Quarless SA. Extraosseous uptake of Tc-99m MDP along the radiation therapy port for recurrent squamous cell carcinoma of the lung. Clin Nucl Med. 2005 Aug; 30(8):555-7.
-
Sodha S, Nagda S, Lackman RD, Donthineni R. Gamma probe assisted biopsy of suspected metastatic rib lesions. Clin Orthop Relat Res. 2004 May; (422):186-9.
-
Balan KK, Choudhary AK, Balan A, Wishart G. Severe systemic reaction to (99m)Tc-methylene diphosphonate: a case report. J Nucl Med Technol. 2003 Jun; 31(2):76-8.
-
Balan KK, Ramkumar S, Faraj K, Choudhary AK. Reduced hemithoracic uptake on 99mTc-MDP bone scintigraphy: an underrecognized sign of massive pleural effusion--a case report. J Nucl Med Technol. 2003 Mar; 31(1):25-6.
-
Medalion B, Katz MG, Lorberboym M, Bder O, Schachner A, Cohen AJ. Decreased sternal vascularity after internal thoracic artery harvesting resolves with time: an assessment with single photon emission computed tomography. J Thorac Cardiovasc Surg. 2002 Mar; 123(3):508-11.
-
Sabbatini P, Larson SM, Kremer A, Zhang ZF, Sun M, Yeung H, Imbriaco M, Horak I, Conolly M, Ding C, Ouyang P, Kelly WK, Scher HI. Prognostic significance of extent of disease in bone in patients with androgen-independent prostate cancer. J Clin Oncol. 1999 Mar; 17(3):948-57.
-
Mandell GA, Contreras SJ, Conard K, Harcke HT, Maas KW. Bone scintigraphy in the detection of chronic recurrent multifocal osteomyelitis. J Nucl Med. 1998 Oct; 39(10):1778-83.
-
Dowe DA, Johnston TA, Showers TL, Kasper JF, Salzman AJ. Tc-99m MDP uptake in stage D adenocarcinoma of the colon. Clin Nucl Med. 1998 Sep; 23(9):620.